CGIX | Complete Cancer Genetics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Cancer Genetics (NASDAQ:CGIX) Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Cancer Genetics, Inc. (CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced that it will effect a 1-for-30 reverse stock split of its CGIX closed up 0.62 percent on Friday, June 5, 2020, on 1.49 times normal volume. It was able to find support at its 50 day moving average. It was able to bounce off of its 200 day moving average, an important long-term support line. Get the latest Cancer Genetics, Inc. (CGIX) stock news and headlines to help you in your trading and investing decisions. Stock quote and company snapshot for CANCER GENETICS INC (CGIX), including profile, stock chart, recent news and events, analyst opinions, and research reports. StockTwits Read live tweets from the financial and investing community about the stock you're interested in. From an enhanced free experience to professional stock picking - we have a great plan for you
VelocityShares Daily 2x VIX ST ETN. TVIX 112.30 3.99 (3.69%). NYSEArca Updated Jun 8, 2020 9:22 PM
Cancer Genetics, Inc. (CGIX) Stock Price, Quote, History ... Find the latest Cancer Genetics, Inc. (CGIX) stock quote, history, news and other vital information to help you with your stock trading and investing. Cancer Genetics, Inc. (CGIX) Stock Forum & Discussion ... Find the latest Cancer Genetics, Inc. (CGIX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. CGIX Conversations From StockTwits - StockNews May 28, 2020
Cancer Genetics Inc (CGIX) Quote | Morningstar
Cancer Genetics (NASDAQ:CGIX) Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Cancer Genetics, Inc. (CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced that it will effect a 1-for-30 reverse stock split of its
Cancer Genetics Inc. - NASDAQ:CGIX - Stock Quote & News ...
CGIX Split History Cancer Genetics (CGIX) has 1 split in our CGIX split history database. The split for CGIX took place on October 25, 2019. This was a 1 for 30 reverse split, meaning for each 30 shares of CGIX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 33.3333333333333 share position following the Cancer Genetics, Inc. (CGIX) Stock: Here’s What’s ... Jul 16, 2019
CGIX Price Target and Analyst Ratings (Cancer Genetics)
Cancer Genetics (NASDAQ:CGIX) Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Cancer Genetics, Inc. (CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced that it will effect a 1-for-30 reverse stock split of its